Martin Lepage uses using functional magnetic resonance imaging (fMRI) to study memory deficits in patients with schizophrenia.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Jocelyne Lahoud is Administrative Director, Research Centre, Douglas Institute

Mimi Israël is active in eating disorders, affective disorders, crisis intervention, emergency psychiatry and mental health care service organization.

Alain Brunet, PhD, studies risk factors and develops effective treatments for PTSD, such as early intervention and reconsolidation blockade.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.  

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.  

Thomas Brown studies the development of psychosocial interventions to combat substance abuse.

Diane B. Boivin, MD, PhD, conducts research as an expert in sleep and circadian rhythms disorders since 1986.